|
2022-07-01 |
2022-07-01 |
V
Vente
|
Potter Stephen W
Chief Business Officer
Dirigeant
|
8 070
-12.6%
0,77
6 250 USD
|
8 070
-12.6%
|
0,77
|
6 250 USD
|
|
|
2022-05-31 |
2022-05-27 |
V
Vente
|
Reynolds Gerald Anthony
Chief Accounting Officer
Dirigeant
|
3 994
-16.0%
0,85
3 376 USD
|
3 994
-16.0%
|
0,85
|
3 376 USD
|
|
|
2022-02-22 |
2022-02-18 |
V
Vente
|
Washer Susan B.
President and CEO
Administrateur exécutif
|
9 950
-6.5%
2,18
21 691 USD
|
9 950
-6.5%
|
2,18
|
21 691 USD
|
|
|
2019-12-30 |
2019-12-26 |
V
Vente
|
Krol Patrick Johan Hendrik
Actionnaire important
|
81 162
-4.4%
5,24
425 289 USD
|
81 162
-4.4%
|
5,24
|
425 289 USD
|
|
|
2019-11-26 |
2019-11-19 |
A
Achat
|
Krol Patrick Johan Hendrik
Actionnaire important
|
2 544
+0.1%
2,79
7 098 USD
|
2 544
+0.1%
|
2,79
|
7 098 USD
|
|
|
2018-12-18 |
2018-12-14 |
V
Vente
|
Shearman Mark S
Chief Scientific Officer
Dirigeant
|
3 000
-100.0%
3,35
10 053 USD
|
3 000
-100.0%
|
3,35
|
10 053 USD
|
|
|
2018-12-18 |
2018-12-14 |
A
Achat
|
Washer Susan B.
President and CEO
Administrateur exécutif
|
2 380
+11.7%
3,34
7 949 USD
|
2 380
+11.7%
|
3,34
|
7 949 USD
|
|
|
2018-12-18 |
2018-12-14 |
A
Achat
|
Rosen James
Administrateur non-exécutif
|
1 000
+inf%
3,38
3 381 USD
|
1 000
+inf%
|
3,38
|
3 381 USD
|
|
|
2018-12-18 |
2018-12-14 |
A
Achat
|
Sullivan William A.
Chief Financial Officer
Dirigeant
|
3 000
+inf%
3,33
9 990 USD
|
3 000
+inf%
|
3,33
|
9 990 USD
|
|
|
2018-12-18 |
2018-12-14 |
A
Achat
|
Aliski William
Administrateur non-exécutif
|
500
+6.2%
3,24
1 620 USD
|
500
+6.2%
|
3,24
|
1 620 USD
|
|
|
2018-12-18 |
2018-12-14 |
A
Achat
|
Aliski William
Administrateur non-exécutif
|
4 300
+116.2%
3,25
13 975 USD
|
4 300
+116.2%
|
3,25
|
13 975 USD
|
|
|
2018-12-18 |
2018-12-14 |
A
Achat
|
Aliski William
Administrateur non-exécutif
|
1 200
+48.0%
3,24
3 882 USD
|
1 200
+48.0%
|
3,24
|
3 882 USD
|
|
|
2016-11-17 |
2016-11-16 |
A
Achat
|
Magovcevic Ivana
Administrateur non-exécutif
|
3 000
+inf%
9,63
28 875 USD
|
3 000
+inf%
|
9,63
|
28 875 USD
|
|
|
2016-11-02 |
2016-11-01 |
VP
Vente planifiée
|
Chulay Jeffrey D.
VP and Chief Medical Officer
Dirigeant
|
1 000
-4.7%
7,05
7 052 USD
|
1 000
-4.7%
|
7,05
|
7 052 USD
|
|
|
2016-09-26 |
2016-09-22 |
A
Achat
|
Shearman Mark S
Chief Scientific Officer
Dirigeant
|
1 300
+76.5%
8,87
11 531 USD
|
1 300
+76.5%
|
8,87
|
11 531 USD
|
|
|
2016-09-26 |
2016-09-22 |
A
Achat
|
Shearman Mark S
Chief Scientific Officer
Dirigeant
|
1 700
+inf%
8,87
15 071 USD
|
1 700
+inf%
|
8,87
|
15 071 USD
|
|
|
2016-09-27 |
2016-09-20 |
A
Achat
|
Potter Stephen W
See Remarks
Dirigeant
|
400
+40.0%
8,69
3 476 USD
|
400
+40.0%
|
8,69
|
3 476 USD
|
|
|
2016-09-20 |
2016-09-19 |
A
Achat
|
BULLOCK LAWRENCE E
Chief Financial Officer
Dirigeant
|
10 000
+inf%
8,75
87 500 USD
|
10 000
+inf%
|
8,75
|
87 500 USD
|
|
|
2016-09-27 |
2016-09-16 |
A
Achat
|
Potter Stephen W
See Remarks
Dirigeant
|
1 000
+inf%
8,97
8 970 USD
|
1 000
+inf%
|
8,97
|
8 970 USD
|
|
|
2015-02-24 |
2015-02-23 |
V
Vente
|
GLAXOSMITHKLINE PLC
|
503 150
-25.9%
22,00
11 069 602 USD
|
503 150
-25.9%
|
22,00
|
11 069 602 USD
|
|
